Tendinopathy Exact Monitoring Schedule

Why a Structured Monitoring Schedule Matters in Tendinopathy

Tendinopathy recovery is slow and nonlinear, which makes structured follow-up essential for both clinician and patient. Without scheduled reassessment windows, patients either abandon exercise-based programs too early or persist with an ineffective protocol for months. A defined monitoring framework anchors treatment decisions to measurable outcomes rather than subjective frustration.

The tendinopathy continuum model proposed by Cook and Purdam describes three overlapping stages: reactive tendinopathy, tendon dysrepair, and degenerative tendinopathy 1. Each stage responds differently to load, and progression between stages is not always linear. Monitoring allows clinicians to identify which stage a patient occupies at each visit and adjust loading accordingly. A 2016 British Journal of Sports Medicine consensus statement recommended that tendon loading programs should be reassessed at minimum every 4 to 6 weeks, with validated patient-reported outcome measures used to track change 2. The NICE Clinical Knowledge Summary for tendinopathy similarly advises structured review at 6 and 12 weeks to determine whether conservative management is working or referral is needed 3.

Abandoning structured loading before the 12-week mark is one of the most common reasons for treatment failure. A systematic review by Malliaras et al. found that exercise-based programs for lower-limb tendinopathy required a minimum of 12 weeks to produce clinically meaningful pain and function improvements 4.

Week 0: Baseline Assessment

The first visit establishes diagnosis, severity, and a quantified starting point against which all future measurements are compared. Record the tendon involved, symptom duration, aggravating activities, and any prior treatments. This single visit determines the entire downstream monitoring plan.

Validated outcome scores. The VISA (Victorian Institute of Sport Assessment) questionnaire family provides tendon-specific scoring. VISA-A covers the Achilles 5, VISA-P targets the patellar tendon 6, and the DASH or quickDASH addresses upper-limb tendons including lateral epicondyle and rotator cuff 7. A VISA-A score below 50 typically indicates moderate-to-severe Achilles tendinopathy. Record a numeric rating scale (NRS) pain score during the most provocative functional test (single-leg heel raise, single-leg decline squat, or resisted wrist extension depending on location).

Imaging at baseline. Routine imaging is not required if clinical diagnosis is confident. The American College of Radiology Appropriateness Criteria rate ultrasound as "usually appropriate" when the diagnosis is uncertain or when ruling out a partial tear 8. If imaging is obtained, document tendon thickness, neovascularity on power Doppler, and any intrasubstance tearing. These become reference values for later comparison.

Load prescription. Prescribe the initial loading program (eccentric, heavy slow resistance, or isometric depending on irritability) and set the first reassessment at week 4. Dr. Jill Cook, who developed the tendinopathy continuum model, has stated: "The biggest mistake in tendon rehab is progressing load based on time alone rather than on the tendon's response to the previous load" 1.

Week 4: First Reassessment

By week 4, early load adaptation should produce measurable change. The primary question is whether the tendon is tolerating the prescribed loading without sustained symptom flares. Expect modest improvement, not resolution.

Repeat the VISA score and NRS pain during the index provocation test. A VISA score improvement of 10 or more points meets the minimal clinically important difference (MCID) for both VISA-A and VISA-P 5. If the score has not changed or has worsened, verify adherence first. A 2015 study of Achilles tendinopathy patients found that only 55% completed the prescribed eccentric program as directed 9. Non-adherence is the most common cause of stalled progress at this stage.

Decision rules at week 4:

• VISA improved 10+ points and pain stable or reduced: continue current program, progress load by 10 to 15%.
• VISA unchanged but pain stable: verify adherence, review technique, consider switching from eccentric to heavy slow resistance or vice versa.
• VISA worsened or pain increased: reduce load by 20 to 30%, add isometric pain-relief sets (45-second holds, 5 repetitions, per Rio et al. 10), and reassess in 2 weeks rather than 4.

Document the specific exercises, sets, repetitions, and external load used. This objective record prevents "protocol drift" where patients unknowingly reduce intensity over time.

Week 8: Mid-Program Check

The week 8 visit confirms the treatment trajectory. Patients on an effective program should show cumulative VISA improvement of 15 to 25 points from baseline. Those who have not responded by week 8 are less likely to respond by week 12, though exceptions exist.

Reassess VISA, NRS pain, and functional capacity (e.g., number of single-leg heel raises to fatigue for Achilles, or pain-free grip strength for lateral epicondyle). Compare tendon irritability after loading sessions. The 24-hour pain response is a reliable clinical marker: if symptoms settle within 24 hours of the most recent loading session, the current dose is appropriate 2.

A Cochrane review of exercise interventions for lateral epicondylalgia found that programs lasting 8 to 12 weeks produced a standardized mean difference of 1.1 (95% CI 0.7 to 1.5) for pain reduction compared with wait-and-see approaches 11. This confirms that measurable benefit should be detectable by the 8-week mark in most cases.

Adjustments at week 8:

• Responding well: begin adding sport-specific or occupation-specific loading (plyometrics for athletes, repetitive grip tasks for manual workers) at low volume.
• Partial response: increase loading frequency from 3 to 5 sessions per week if tolerated, or trial adjunctive isometrics pre-activity.
• No response: order imaging if not yet obtained. Consider referral to a sports medicine physician for procedural options.

Week 12: The Escalation Decision Point

Twelve weeks is the standard trial duration for exercise-based tendinopathy management. This visit is binary. Either the program has produced sufficient improvement to continue conservative care, or escalation is warranted.

Repeat all baseline measures: VISA score, NRS pain, functional test performance, and (if previously obtained) ultrasound to assess structural change. Tendon thickness reduction and decreased neovascularity on ultrasound correlate with clinical improvement in Achilles tendinopathy 12. A patient who has achieved a VISA score above 70 and can perform their target activities with NRS pain of 3 or less is a treatment responder. Transition this patient to maintenance loading.

For non-responders, the evidence supports several escalation options. A 2021 network meta-analysis in the British Medical Journal compared PRP, corticosteroid injection, shockwave therapy, and continued exercise for various tendinopathies 13. PRP showed moderate benefit over placebo for patellar and lateral elbow tendinopathy at 6 months, while corticosteroid injections provided short-term relief (4 to 6 weeks) but worse long-term outcomes than exercise alone. Extracorporeal shockwave therapy (ESWT) demonstrated a pooled effect size of 0.49 (95% CI 0.22 to 0.76) over sham for calcific rotator cuff tendinopathy 14.

The British Medical Association's best practice guidelines state: "Corticosteroid injection should not be offered as first-line treatment for tendinopathy, as evidence consistently shows poorer long-term outcomes compared with structured loading programs" 13.

Post-Procedure Monitoring (If Escalated)

Patients who receive PRP, ESWT, or sclerosing injections need their own follow-up cadence layered on top of continued loading. The procedure is not a replacement for exercise. It is an adjunct.

PRP follow-up timeline. After PRP injection, restrict high-load activity for 7 to 14 days. Resume modified loading at week 2 post-injection. Reassess with VISA and NRS at 6 weeks and 12 weeks post-injection. De Vos et al. conducted a double-blind RCT (N=54) of PRP vs. saline injection for chronic Achilles tendinopathy and found no significant difference in VISA-A scores at 24 weeks, though both groups improved substantially from baseline (mean VISA-A improvement of 21.7 points) 15. More recent evidence from Fitzpatrick et al. (2017) in a systematic review of 18 RCTs suggested that leukocyte-rich PRP preparations may outperform leukocyte-poor formulations for tendinopathy 16.

ESWT follow-up. Post-ESWT reassessment occurs at 4 and 12 weeks. A 2020 meta-analysis of 13 RCTs found that ESWT produced clinically meaningful improvement in 60 to 70% of patients with calcific shoulder tendinopathy by 12 weeks 14. Patients who do not respond to a course of 3 to 5 ESWT sessions should be referred for surgical consultation.

Maintenance Phase: Months 3 to 12 After Symptom Resolution

Tendon remodeling continues long after pain resolves. A patient who feels "cured" at week 16 still has immature collagen that is vulnerable to re-injury under high load. Maintenance monitoring prevents relapse.

Schedule follow-up visits at 3, 6, and 12 months after transitioning from the active loading phase. At each visit, repeat the VISA score and ask specifically about return of morning stiffness, post-activity soreness lasting beyond 24 hours, and any activity modifications. A VISA score drop of 10 or more points from the peak value warrants restarting a structured loading cycle.

Kongsgaard et al. demonstrated in an RCT (N=39) comparing heavy slow resistance (HSR) to eccentric exercise for patellar tendinopathy that both groups maintained VISA-P improvements at 6-month follow-up, but the HSR group reported higher patient satisfaction (100% vs. 80%) and better collagen turnover markers on ultrasound 17. This suggests that the loading modality chosen for maintenance may influence long-term structural outcomes, though the clinical significance of these differences remains debated.

Athletes returning to sport should maintain at least 2 tendon-specific loading sessions per week indefinitely, reduced from the treatment-phase frequency of 3 to 5 sessions. A prospective cohort study of elite volleyball players found that those who continued heavy slow resistance training during the competitive season had a 44% lower recurrence rate of patellar tendinopathy over 12 months compared with those who stopped 18.

Imaging Triggers Throughout the Monitoring Timeline

Not every visit requires imaging. Ultrasound or MRI should be ordered at specific decision points, not as routine surveillance. Overuse of imaging leads to incidental findings that can derail an effective conservative program.

Order imaging when:

• Diagnosis is uncertain at baseline (rule out partial tear, bursitis, or enthesopathy).
• No clinical improvement by week 12 despite confirmed adherence.
• Acute worsening of symptoms suggesting superimposed partial tear.
• Pre-procedural planning for PRP or ESWT (to confirm correct injection target and exclude full-thickness tear).
• Post-surgical follow-up at 6 and 12 weeks.

Ultrasound is preferred for superficial tendons (Achilles, patellar, lateral epicondyle) due to dynamic assessment capability, lower cost, and absence of radiation 8. MRI is superior for deep tendons (rotator cuff, hip abductors) and when surgical planning requires detailed assessment of tear morphology. A 2019 systematic review found that ultrasound had 87% sensitivity and 94% specificity for diagnosing Achilles tendinopathy compared with MRI as the reference standard 19.

Red Flags That Accelerate the Timeline

Certain findings at any visit should bypass the standard schedule and prompt immediate action. Night pain unresponsive to NSAIDs, rapidly progressive weakness, or palpable defect in the tendon all warrant urgent imaging within 7 days. A sudden inability to perform a previously tolerated provocation test (e.g., inability to single-leg heel raise after previously completing 20 repetitions) raises suspicion for an acute-on-chronic tear.

Systemic features such as bilateral tendinopathy, tendon rupture with minimal trauma, or tendinopathy in a patient under 30 with no clear mechanical overload should trigger investigation for fluoroquinolone exposure, inflammatory arthropathy, or familial hypercholesterolemia. Fluoroquinolone-associated tendinopathy affects approximately 0.14 to 0.4% of exposed patients, with the Achilles tendon involved in 90% of cases 20. If a patient is currently taking a fluoroquinolone, discontinue it and notify the prescriber immediately.

Patients on long-term corticosteroids, aromatase inhibitors, or statins also carry elevated tendinopathy risk and may require more frequent monitoring intervals (every 3 weeks rather than every 4 during the active phase) to detect early deterioration 20.